Skin injection study asks: keep going or take a break?

NCT ID NCT04179175

Ongoing Disease control Sponsor: Novartis Pharmaceuticals Source: ClinicalTrials.gov ↗

Summary

This study aims to find out if people with moderate to severe hidradenitis suppurativa (HS) who improved on a medication called secukinumab should continue treatment or can safely take a break. About 700 participants who already responded to the drug in earlier studies will be randomly assigned to either keep getting injections or switch to a placebo for a year to see if their skin condition stays under control. The main goal is to understand the best long-term approach for managing this painful skin condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Medical Research

Sandy Springs, Georgia, 30328, United States
Austin Inst for Clinical Research

Pflugerville, Texas, 78660, United States
Bellaire Dermatology Associates

Bellaire, Texas, 77401, United States
Beth Israel Deaconess Med Center

Boston, Massachusetts, 02215, United States
Clinical Research Ctr of Carolinas

Charleston, South Carolina, 29407, United States
Dawes Fretzin Clinical Rea Group

Indianapolis, Indiana, 46256, United States
Dr. Stephen Miller, MDPA

San Antonio, Texas, 78229, United States
Dundee Dermatology

West Dundee, Illinois, 60118, United States
Endeavor Health

Glenview, Illinois, 60077, United States
Florida Academic Centers Research and Education LLC

Coral Gables, Florida, 33134, United States
Icahn School Of Med At Mount Sinai

New York, New York, 10029, United States
MDRI Baylor University

Dallas, Texas, 75246-1613, United States
MedDerm Associates

San Diego, California, 92103, United States
MediSearch Clinical Trials

Saint Joseph, Missouri, 64506, United States
Minnesota Clinical Study Center

New Brighton, Minnesota, 55112, United States
Northwest Arkansas Center

Rogers, Arkansas, 72758, United States
Novartis Investigative Site

CABA, Buenos Aires, C1056ABI, Argentina
Novartis Investigative Site

La Plata, Buenos Aires, B1902COS, Argentina
Novartis Investigative Site

Rosario, Santa Fe Province, 2000, Argentina
Novartis Investigative Site

Buenos Aires, C1425DKG, Argentina
Novartis Investigative Site

Caba, C1425BEA, Argentina
Novartis Investigative Site

Capital Federal, C1023AAB, Argentina
Novartis Investigative Site

Phillip, Australian Capital Territory, 2606, Australia
Novartis Investigative Site

Benowa, Queensland, 4217, Australia
Novartis Investigative Site

East Melbourne, Victoria, 3002, Australia
Novartis Investigative Site

Linz, 4020, Austria
Novartis Investigative Site

Vienna, 1090, Austria
Novartis Investigative Site

Brussels, Brussels Capital, 1070, Belgium
Novartis Investigative Site

Ghent, 9000, Belgium
Novartis Investigative Site

Liège, 4000, Belgium
Novartis Investigative Site

Pleven, 5800, Bulgaria
Novartis Investigative Site

Sofia, 1407, Bulgaria
Novartis Investigative Site

Sofia, 1606, Bulgaria
Novartis Investigative Site

Stara Zagora, 6000, Bulgaria
Novartis Investigative Site

Barrie, Ontario, L4M 7G1, Canada
Novartis Investigative Site

London, Ontario, N6H 5L5, Canada
Novartis Investigative Site

Peterborough, Ontario, K9J 5K2, Canada
Novartis Investigative Site

Waterloo, Ontario, N2J 1C4, Canada
Novartis Investigative Site

Barranquilla, Atlántico, 080002, Colombia
Novartis Investigative Site

Zagreb, HRV, 10000, Croatia
Novartis Investigative Site

Prague, Prague 1, 11000, Czechia
Novartis Investigative Site

Jihlava, 586 01, Czechia
Novartis Investigative Site

Plzen Bory, 301 00, Czechia
Novartis Investigative Site

Ústí nad Labem, 400 11, Czechia
Novartis Investigative Site

Limoges, Haute Vienne, 87000, France
Novartis Investigative Site

Toulon, Val De Marne, 83800, France
Novartis Investigative Site

Antony, 92160, France
Novartis Investigative Site

Bordeaux, 33075, France
Novartis Investigative Site

Brest, 29609, France
Novartis Investigative Site

Créteil, 94010, France
Novartis Investigative Site

Lyon, 69003, France
Novartis Investigative Site

Martigues, 13500, France
Novartis Investigative Site

Montpellier, 34295, France
Novartis Investigative Site

Nantes, 44093, France
Novartis Investigative Site

Nice, 06202, France
Novartis Investigative Site

Paris, 75475, France
Novartis Investigative Site

Reims, 51100, France
Novartis Investigative Site

Rouen, 76031, France
Novartis Investigative Site

Saint-Mandé, 94160, France
Novartis Investigative Site

Saint-Priest-en-Jarez, 42270, France
Novartis Investigative Site

Toulouse, 31400, France
Novartis Investigative Site

Langenau, Baden-Wurttemberg, 89129, Germany
Novartis Investigative Site

Munich, Bavaria, 81377, Germany
Novartis Investigative Site

Würzburg, Bavaria, 97080, Germany
Novartis Investigative Site

Halle, Saxony-Anhalt, 06108, Germany
Novartis Investigative Site

Berlin, 10789, Germany
Novartis Investigative Site

Berlin, 13353, Germany
Novartis Investigative Site

Bielefeld, 33647, Germany
Novartis Investigative Site

Bochum, 44791, Germany
Novartis Investigative Site

Erlangen, 91054, Germany
Novartis Investigative Site

Frankfurt, 60590, Germany
Novartis Investigative Site

Hamburg, 20246, Germany
Novartis Investigative Site

Heidelberg, 69120, Germany
Novartis Investigative Site

Memmingen, 87700, Germany
Novartis Investigative Site

München, 80377, Germany
Novartis Investigative Site

Münster, 48149, Germany
Novartis Investigative Site

Potsdam, 14467, Germany
Novartis Investigative Site

Schwerin, 19055, Germany
Novartis Investigative Site

Athens, 161 21, Greece
Novartis Investigative Site

Chaïdári, 124 62, Greece
Novartis Investigative Site

Thessaloniki, 546 43, Greece
Novartis Investigative Site

Thessaloniki, 564 03, Greece
Novartis Investigative Site

Guatemala City, 01010, Guatemala
Novartis Investigative Site

Guatemala City, 1015, Guatemala
Novartis Investigative Site

Pécs, Baranya, 7623, Hungary
Novartis Investigative Site

Debrecen, Hajdu Bihar Megye, 4032, Hungary
Novartis Investigative Site

Kaposvár, 7400, Hungary
Novartis Investigative Site

Mysore, Karnataka, 570001, India
Novartis Investigative Site

Nagpur, Maharashtra, 440009, India
Novartis Investigative Site

Nashik, Maharashtra, 422101, India
Novartis Investigative Site

New Delhi, National Capital Territory of Delhi, 110060, India
Novartis Investigative Site

Jerusalem, 9112001, Israel
Novartis Investigative Site

Petah Tikva, 4941492, Israel
Novartis Investigative Site

Ramat Gan, 5265601, Israel
Novartis Investigative Site

Tel Aviv, 6423906, Israel
Novartis Investigative Site

Ancona, AN, 60126, Italy
Novartis Investigative Site

Cona, FE, 44124, Italy
Novartis Investigative Site

Florence, FI, 50122, Italy
Novartis Investigative Site

Milan, MI, 20122, Italy
Novartis Investigative Site

Pisa, PI, 56126, Italy
Novartis Investigative Site

Roma, RM, 00133, Italy
Novartis Investigative Site

Naples, 80131, Italy
Novartis Investigative Site

Nagoya, Aichi-ken, 4678602, Japan
Novartis Investigative Site

Kisarazu, Chiba, 292-8535, Japan
Novartis Investigative Site

Ginowan, Okinawa, 901 2222, Japan
Novartis Investigative Site

Koshigaya, Saitama, 343-8555, Japan
Novartis Investigative Site

Itabashi-ku, Tokyo, 1738610, Japan
Novartis Investigative Site

Osaka, 5458586, Japan
Novartis Investigative Site

Saida, 652, Lebanon
Novartis Investigative Site

Kaunas, LTU, LT 50161, Lithuania
Novartis Investigative Site

Vilnius, LT-08406, Lithuania
Novartis Investigative Site

Kuala Lumpur, Kuala Lumpur, 50586, Malaysia
Novartis Investigative Site

George Town, Pulau Pinang, 10450, Malaysia
Novartis Investigative Site

Johor Bahru, 80100, Malaysia
Novartis Investigative Site

Guadalajara, Jalisco, 44638, Mexico
Novartis Investigative Site

Monterrey, Nuevo León, 64460, Mexico
Novartis Investigative Site

Amersfroort, Utrecht, 3813 TZ, Netherlands
Novartis Investigative Site

Las Piñas, 1740, Philippines
Novartis Investigative Site

Makati City, 1220, Philippines
Novartis Investigative Site

Warsaw, Mazowian, 02 495, Poland
Novartis Investigative Site

Ossy, 42-624, Poland
Novartis Investigative Site

Rzeszów, 35 055, Poland
Novartis Investigative Site

Warsaw, 02-776, Poland
Novartis Investigative Site

Warsaw, 04-141, Poland
Novartis Investigative Site

Wroclaw, 50-566, Poland
Novartis Investigative Site

Lisbon, 1169-050, Portugal
Novartis Investigative Site

Lisbon, 1998-018, Portugal
Novartis Investigative Site

Porto, 4099-001, Portugal
Novartis Investigative Site

Chelyabinsk, 454048, Russia
Novartis Investigative Site

Kazan', 420012, Russia
Novartis Investigative Site

Krasnodar, 350020, Russia
Novartis Investigative Site

Saint Petersburg, 197022, Russia
Novartis Investigative Site

Saint Petersburg, 197198, Russia
Novartis Investigative Site

Smolensk, 214031, Russia
Novartis Investigative Site

Yaroslavl, 150003, Russia
Novartis Investigative Site

Singapore, 119074, Singapore
Novartis Investigative Site

Singapore, 308205, Singapore
Novartis Investigative Site

Banská Bystrica, 975 17, Slovakia
Novartis Investigative Site

Košice, 041 90, Slovakia
Novartis Investigative Site

Prešov, 081 81, Slovakia
Novartis Investigative Site

Raslouw Centurion, Gauteng, 0157, South Africa
Novartis Investigative Site

Soweto, Gauteng, 2013, South Africa
Novartis Investigative Site

Seoul, Korea, 02841, South Korea
Novartis Investigative Site

Seoul, Korea, 03080, South Korea
Novartis Investigative Site

Seoul, 07441, South Korea
Novartis Investigative Site

Cadiz, Andalusia, 11009, Spain
Novartis Investigative Site

Granada, Andalusia, 18014, Spain
Novartis Investigative Site

Barcelona, Catalonia, 08003, Spain
Novartis Investigative Site

Fuenlabrada, Madrid, 28942, Spain
Novartis Investigative Site

Manises, Valencia, 46940, Spain
Novartis Investigative Site

Alicante, 03010, Spain
Novartis Investigative Site

Barcelona, 08041, Spain
Novartis Investigative Site

Las Palmas GC, 35010, Spain
Novartis Investigative Site

Madrid, 28006, Spain
Novartis Investigative Site

Madrid, 28009, Spain
Novartis Investigative Site

Pontevedra, 36003, Spain
Novartis Investigative Site

Bern, 3010, Switzerland
Novartis Investigative Site

Geneva, 1211, Switzerland
Novartis Investigative Site

Lausanne, 1011, Switzerland
Novartis Investigative Site

Taipei, 10002, Taiwan
Novartis Investigative Site

Taoyuan District, 33305, Taiwan
Novartis Investigative Site

Aydin, Efeler, 09100, Turkey (Türkiye)
Novartis Investigative Site

Istanbul, Fatih, 34098, Turkey (Türkiye)
Novartis Investigative Site

Antalya, Konyaalti, 07070, Turkey (Türkiye)
Novartis Investigative Site

Kayseri, Melikgazi, 38039, Turkey (Türkiye)
Novartis Investigative Site

Istanbul, Pendik, 34899, Turkey (Türkiye)
Novartis Investigative Site

Gaziantep, Sehitkamil, 27310, Turkey (Türkiye)
Novartis Investigative Site

Exeter, Devon, EX2 5DW, United Kingdom
Novartis Investigative Site

Dudley, West Midlands, DY1 2HQ, United Kingdom
Novartis Investigative Site

Bradford, West Yorkshire, BD5 0NA, United Kingdom
Novartis Investigative Site

Leeds, West Yorkshire, LS7 4SA, United Kingdom
Novartis Investigative Site

Barnsley, S75 2EP, United Kingdom
Novartis Investigative Site

Bristol, BS1 3NU, United Kingdom
Novartis Investigative Site

London, E11 1NR, United Kingdom
Novartis Investigative Site

London, SE1 9RT, United Kingdom
Novartis Investigative Site

Salford, M6 8HD, United Kingdom
Novartis Investigative Site

Hanoi, 100000, Vietnam
Novartis Investigative Site

Ho Chi Minh City, 700000, Vietnam
Olympian Clinical Research

Tampa, Florida, 33609, United States
Skin Specialists PC

Omaha, Nebraska, 68144, United States
Southern California Skin and Laser

Whittier, California, 92677, United States
St Louis U Clinical Trials

St Louis, Missouri, 63104, United States
Tufts Medical Center

Boston, Massachusetts, 02111, United States
UP Medical Center H System

Pittsburgh, Pennsylvania, 15213-3403, United States
University Clinical Trials

San Diego, California, 92123, United States
University Of South Florida

Tampa, Florida, 33612, United States
University of MiamiHealth System

Miami, Florida, 33125, United States
University of North Carolina

Chapel Hill, North Carolina, 27516, United States
Virginia Clinical Research

Norfolk, Virginia, 23507, United States
WA Uni School Of Med

St Louis, Missouri, 63110, United States
Wright State University

Fairborn, Ohio, 45324, United States

Conditions

Explore the condition pages connected to this study.

HIDRADENITIS SUPPURATIVA